Yun H, et al. Do Patients with Moderate or High Disease Activity Escalate RA Therapy According to Treat-to-Target Principles? Results from the ACR’s RISE Registry. ACR 2018, abstract 2856.
Voorspellers voor inadequate MTX-respons in U-Act-Early
nov 2018 | Reumatoïde artritis